Journals / Kocaeli Tıp Dergisi / 2021 / Cilt: 10 - Sayı: 2

The Relationship Between Parenchymal Findings of Chest ComputedTomography and C Reactive Protein in COVID-19 Patients at HospitalAdmission

Hastaneye Yatırılan COVID-19 Hastalarında Akciğer Bilgisayarlı Tomografi Parankimal Bulguları ile C Reaktif Protein Arasındaki İlişki

Pages
160–166
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

DISCUSSION AND CONCLUSION: In our study, we found that patients with atypical findings as nodules had lower CRP levels than those with typical findings on chest CT in symptomatic COVID-19 patients admitted to the hospital.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:INTRODUCTION: In this study, we aimed to investigate the relationship between the parenchymal findings of COVID-19 pneumonia on chest Coumputed Tomography (CT) and C reactive protein (CRP) at hospital admission.
📊
Key Findings & Data:METHODS: 192 consecutive COVID-19 patients with pulmonary findings on chest CT, who were admitted to the hospital between 1st April to 30th May 2020, were included in the study.
💡
Conclusion & Impact:DISCUSSION AND CONCLUSION: In our study, we found that patients with atypical findings as nodules had lower CRP levels than those with typical findings on chest CT in symptomatic COVID-19 patients admitted to the hospital.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

INTRODUCTION: In this study, we aimed to investigate the relationship between the parenchymal findings of COVID-19 pneumonia on chest Coumputed Tomography (CT) and C reactive protein (CRP) at hospital admission. METHODS: 192 consecutive COVID-19 patients with pulmonary findings on chest CT, who were admitted to the hospital between 1st April to 30th May 2020, were included in the study. COVID-19 pulmonary findings were evaluated in admission chest CT RESULTS: Median age of 192 patients was 44 (31-59) years and 46.8% (90) of them were female. Median CRP value was found to be 15.2mg/L (2.0-55). Chest CT findigs of the patients were as follows: 69.2% (133) with ground glass opacity, 33.8% (65) with consolidation, 6.2% (12) with reversed halo, 11.9% (23) with crazy-paving, 20.8% (40) with discrete nodula, 5.7% (11) with pulmonary vascular enlargement, 3.6% (7) with bronchiectasis and 17.1% (33) with fibrosis. The mean CRP was found to be 42.8±59.1 in patients without nodule presentation and 34.7±53.2 in patients with nodule presentation. In order to determine independent predictors related to CRP; chest CT parameters described above were assessed in the linear regression. Association with statisticaly significance were determined between the presence of nodule on chest CT (-26.1CI 95%; (-49.0,-3.1), p = 0.026), BSTI-CT score (20.6, CI 95%; 7.6, 33.6, p= 0.002) and CRP values. DISCUSSION AND CONCLUSION: In our study, we found that patients with atypical findings as nodules had lower CRP levels than those with typical findings on chest CT in symptomatic COVID-19 patients admitted to the hospital.

Özet

GİRİŞ ve AMAÇ: Bu çalışmada, hastaneye yatışta Toraks Bilgisayarlı Tomografide (BT) COVID-19 pnömonisine ait parankimal bulguların C reaktif protein (CRP) ile ilişkisini araştırmayı amaçladık. YÖNTEM ve GEREÇLER: 1 Nisan-30 Mayıs 2020 tarihleri arasında akciğer tomografisinde akciğer bulguları saptanan ve hastaneye başvuran ardışık 192 COVID-19 hastası çalışmaya dahil edildi. COVID-19 pulmoner bulguları başvuru Toraks BT ile değerlendirildi BULGULAR: 192 hastanın ortanca yaşı 44 (31-59) yıl olup, bunların %46,8'i (90) kadındı. Medyan CRP değeri 15.2mg/L (2.0-55) olarak bulundu. Hastaların Toraks BT bulguları şöyleydi: %69.2 (133) buzlu cam opaklığı, %33.8 (65) konsolidasyon, %6.2 (12) ters halo, %11.9 (23) çılgın kaldırım, %20.8 ( 40) ayrık nodül, %5.7 (11) pulmoner vasküler genişleme, %3.6 (7) bronşektazi ve %17.1 (33) fibrozis ile. Nodül prezentasyonu olmayan hastalarda ortalama CRP 42,8±59,1 nodül prezentasyonu olan hastalarda ise 34,7±53,2 bulundu. CRP ile ilgili bağımsız öngörücüleri belirlemek için; Yukarıda açıklanan göğüs BT parametreleri lineer regresyonda değerlendirildi. Göğüs BT'sinde nodül varlığı (-26.1CI %95; (-49.0,-3.1), p = 0.026), BSTI-CT skoru (20,6, CI %95; 7.6, 33.6, p) arasında istatistiksel olarak anlamlı ilişki saptandı. = 0,002) ve CRP değerleri. TARTIŞMA ve SONUÇ: Çalışmamızda, hastaneye başvuran semptomatik COVID-19 hastalarında nodül gibi atipik bulguları olan hastaların Toraks BT'sinde tipik bulguları olanlara göre CRP düzeylerinin daha düşük olduğunu bulduk.

🔖

Cite This Article

ALTINTAŞ, D. D., ŞENOL, A. (2022). The Relationship Between Parenchymal Findings of Chest ComputedTomography and C Reactive Protein in COVID-19 Patients at HospitalAdmission. Kocaeli Tıp Dergisi, Cilt: 10 - Sayı: 2, 160–166. https://ajindex.com/articles/652943

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Shah A, Kashyap R, Tosh P, Sampathkumar P, O’Horo JC. Guide to Understanding the 2019 NovelCoronavirus. Mayo Clin Proc. 2020; Apr;95(4):646- 652
  2. Mahase E. Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and in action. BMJ. 2020;368:m1036. doi: 10.1136/bmj.m1036
  3. Lippi G, Sanchis-Gomar F, Henry BM. Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm. AnnTranslMed 2020; 2020 Apr;8(7):497.doi: 10.21037/atm.2020.03.157
  4. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RTPCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020 Aug;296(2):E32-E40.doi: 10.1148/radiol.2020200642
  5. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of chest CT for COVID-19: comparison to RTPCR. Radiology 2020 Aug;296(2):E115-E117.doi: 10.1148/radiol.2020200432
  6. Revel M-P, Parkar AP, Prosch H, Silva M, Sverzellati M, Gleeson F, et al. COVID-19 patients and the radiology department–advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). EurRadiol. 2020 Sep;30(9):4903-4909.doi: 10.1007/s00330-020-06865-y
  7. Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time course of lungchanges at chest CT during recovery from coronavirus disease 2019 (COVID-19). 2020 Jun;295(3):715-721. doi: 10.1148/radiol.2020200370
  8. Hani C, Trieu NH, Saab I, Dangeard S, Bennani S, Chassagnon G, et al. COVID-19 pneumonia: a review of typical CT findings and differential diagnosis. Diagn Interv Imagin 2020 May;101(5):263-268.doi: 10.1016/j.diii.2020.03.014
  9. Wen Z, Chi Y, Zhang L, Liu H, Du K, Li Z, et al. Coronavirus disease 2019: initial detection on chest CT in a retrospective Multicenter study of 103 chinese subjects. Radiology:Cardiothoracic Imaging 2020; 200092. doi.org/10.1148/ryct.2020200092
  10. Inui S, Fujikawa A, Jitsu M, Kunishima N, Watanabe S, Suzuki Y, et al. Chest CT findings in cases from the cruise ship “Diamond Princess” with coronavirus disease 2019 (COVID-19). Radiology Cardiothoracic Imaging. 2020; 200110.doi.org/10.1148/ryct.2020200110 11. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang Pet al. Sensitivity of chest CT for COVID19: Comparison to RTPCR. Radiology. 2020 Aug;296(2):E115-E117.doi: 10.1148/radiol.2020200432
  11. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JA